|
1
|
Rodríguez-Paredes M and Esteller M: Cancer
epigenetics reaches mainstream oncology. Nat Med. 17:330–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fraga MF, Ballestar E, Villar-Garea A,
Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S,
Petrie K, et al: Loss of acetylation at Lys16 and trimethylation at
Lys20 of histone H4 is a common hallmark of human cancer. Nat
Genet. 37:391–400. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wood LD, Parsons DW, Jones S, Lin J,
Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al: The
genomic landscapes of human breast and colorectal cancers. Science.
318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carmona FJ and Esteller M: Moving closer
to a prognostic DNA methylation signature in colon cancer. Clin
Cancer Res. 17:1215–1217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Irizarry RA, Ladd-Acosta C, Wen B, Wu Z,
Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, et al:
The human colon cancer methylome shows similar hypo- and
hypermethylation at conserved tissue-specific CpG island shores.
Nat Genet. 41:178–186. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang X, Tan J, Li J, Kivimäe S, Yang X,
Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, et al: DACT3 is an
epigenetic regulator of Wnt/beta-catenin signaling in colorectal
cancer and is a therapeutic target of histone modifications. Cancer
Cell. 13:529–541. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fluge Ø, Gravdal K, Carlsen E, Vonen B,
Kjellevold K, Refsum S, Lilleng R, Eide TJ, Halvorsen TB, Tveit KM,
et al: Expression of EZH2 and Ki-67 in colorectal cancer and
associations with treatment response and prognosis. Br J Cancer.
101:1282–1289. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamamoto S, Tateishi K, Kudo Y, Yamamoto
K, Isagawa T, Nagae G, Nakatsuka T, Asaoka Y, Ijichi H, Hirata Y,
et al: Histone demethylase KDM4C regulates sphere formation by
mediating the cross talk between Wnt and Notch pathways in colonic
cancer cells. Carcinogenesis. 34:2380–2388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shinkai Y and Tachibana M: H3K9
methyltransferase G9a and the related molecule GLP. Genes Dev.
25:781–788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maze I, Covington HE III, Dietz DM,
LaPlant Q, Renthal W, Russo SJ, Mechanic M, Mouzon E, Neve RL,
Haggarty SJ, et al: Essential role of the histone methyltransferase
G9a in cocaine-induced plasticity. Science. 327:213–216. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thomas LR, Miyashita H, Cobb RM, Pierce S,
Tachibana M, Hobeika E, Reth M, Shinkai Y and Oltz EM: Functional
analysis of histone methyltransferase g9a in B and T lymphocytes. J
Immunol. 181:485–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Katoh K, Yamazaki R, Onishi A, Sanuki R
and Furukawa T: G9a histone methyltransferase activity in retinal
progenitors is essential for proper differentiation and survival of
mouse retinal cells. J Neurosci. 32:17658–17670. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ueda J, Ho JC, Lee KL, Kitajima S, Yang H,
Sun W, Fukuhara N, Zaiden N, Chan SL, Tachibana M, et al: The
hypoxia-inducible epigenetic regulators Jmjd1a and G9a provide a
mechanistic link between angiogenesis and tumor growth. Mol Cell
Biol. 34:3702–3720. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen X, Skutt-Kakaria K, Davison J, Ou YL,
Choi E, Malik P, Loeb K, Wood B, Georges G, Torok-Storb B and
Paddison PJ: G9a/GLP-dependent histone H3K9me2 patterning during
human hematopoietic stem cell lineage commitment. Genes Dev.
26:2499–2511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ke XX, Zhang D, Zhu S, Xia Q, Xiang Z and
Cui H: Inhibition of H3K9 methyltransferase G9a repressed cell
proliferation and induced autophagy in neuroblastoma cells. PLoS
One. 9:e1069622014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang J, Dorsey J, Chuikov S, Pérez-Burgos
L, Zhang X, Jenuwein T, Reinberg D and Berger SL: G9a and Glp
methylate lysine 373 in the tumor suppressor p53. J Biol Chem.
285:9636–9641. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kondo Y, Shen L, Suzuki S, Kurokawa T,
Masuko K, Tanaka Y, Kato H, Mizuno Y, Yokoe M, Sugauchi F, et al:
Alterations of DNA methylation and histone modifications contribute
to gene silencing in hepatocellular carcinomas. Hepatol Res.
37:974–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim Y, Kim YS, Kim DE, Lee JS, Song JH,
Kim HG, Cho DH, Jeong SY, Jin DH, Jang SJ, et al: BIX-01294 induces
autophagy-associated cell death via EHMT2/G9a dysfunction and
intracellular reactive oxygen species production. Autophagy.
9:2126–2139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, He P, Xi Y, Geng M, Chen Y and
Ding J: Down-regulation of G9a triggers DNA damage response and
inhibits colorectal cancer cells proliferation. Oncotarget.
6:2917–2927. 2015.PubMed/NCBI
|
|
22
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kyriakos M: The President's cancer, the
Dukes classification, and confusion. Arch Pathol Lab Med.
109:1063–1066. 1985.PubMed/NCBI
|
|
24
|
Barresi V, Bonetti Reggiani L, Ieni A,
Caruso RA and Tuccari G: Histological grading in colorectal cancer:
New insights and perspectives. Histol Histopathol. 30:1059–1067.
2015.PubMed/NCBI
|
|
25
|
Zeng Z, Wu HX, Zhan N, Huang YB, Wang ZS,
Yang GF, Wang P and Fu GH: Prognostic significance of USP10 as a
tumor-associated marker in gastric carcinoma. Tumour Biol.
35:3845–3853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tripathi MK, Deane NG, Zhu J, An H, Mima
S, Wang X, Padmanabhan S, Shi Z, Prodduturi N, Ciombor KK, et al:
Nuclear factor of activated T-cell activity is associated with
metastatic capacity in colon cancer. Cancer Res. 74:6947–6957.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Laibe S, Lagarde A, Ferrari A, Monges G,
Birnbaum D and Olschwang S: COL2 Project: A seven-gene signature
aggregates a subgroup of stage II colon cancers with stage III.
OMICS. 16:560–565. 2012.PubMed/NCBI
|
|
29
|
Loboda A, Nebozhyn MV, Watters JW, Buser
CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB,
Agrawal D, et al: EMT is the dominant program in human colon
cancer. BMC Med Genomics. 4:92011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Freeman TJ, Smith JJ, Chen X, Washington
MK, Roland JT, Means AL, Eschrich SA, Yeatman TJ, Deane NG and
Beauchamp RD: Smad4-mediated signaling inhibits intestinal
neoplasia by inhibiting expression of β-catenin. Gastroenterology.
142:562–571.e2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gröne J, Lenze D, Jurinovic V, Hummel M,
Seidel H, Leder G, Beckmann G, Sommer A, Grützmann R, Pilarsky C,
et al: Molecular profiles and clinical outcome of stage UICC II
colon cancer patients. Int J Colorectal Dis. 26:847–858. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kemper K, Versloot M, Cameron K, Colak S,
de Sousa e Melo F, de Jong JH, Bleackley J, Vermeulen L, Versteeg
R, Koster J and Medema JP: Mutations in the Ras-Raf Axis underlie
the prognostic value of CD133 in colorectal cancer. Clin Cancer
Res. 18:3132–3141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Sousa E, Melo F, Colak S, Buikhuisen J,
Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR,
Fessler E, van den Bergh SP, et al: Methylation of
cancer-stem-cell-associated Wnt target genes predicts poor
prognosis in colorectal cancer patients. Cell Stem Cell. 9:476–485.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mootha VK, Lindgren CM, Eriksson KF,
Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E,
Ridderstråle M, Laurila E, et al: PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat Genet. 34:267–273. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kaiser S, Park YK, Franklin JL, Halberg
RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, et
al: Transcriptional recapitulation and subversion of embryonic
colon development by mouse colon tumor models and human colon
cancer. Genome Biol. 8:R1312007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gaedcke J, Grade M, Jung K, Camps J, Jo P,
Emons G, Gehoff A, Sax U, Schirmer M, Becker H, et al: Mutated KRAS
results in overexpression of DUSP4, a MAP-kinase phosphatase, and
SMYD3, a histone methyltransferase, in rectal carcinomas. Genes
Chromosomes Cancer. 49:1024–1034. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hong Y, Downey T, Eu KW, Koh PK and Cheah
PY: A ‘metastasis-prone’ signature for early-stage mismatch-repair
proficient sporadic colorectal cancer patients and its implications
for possible therapeutics. Clin Exp Metastasis. 27:83–90. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tachibana M, Sugimoto K, Nozaki M, Ueda J,
Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H and Shinkai Y:
G9a histone methyltransferase plays a dominant role in euchromatic
histone H3 lysine 9 methylation and is essential for early
embryogenesis. Genes Dev. 16:1779–1791. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cho HS, Kelly JD, Hayami S, Toyokawa G,
Takawa M, Yoshimatsu M, Tsunoda T, Field HI, Neal DE, Ponder BA, et
al: Enhanced expression of EHMT2 is involved in the proliferation
of cancer cells through negative regulation of SIAH1. Neoplasia.
13:676–684. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen MW, Hua KT, Kao HJ, Chi CC, Wei LH,
Johansson G, Shiah SG, Chen PS, Jeng YM, Cheng TY, et al: H3K9
histone methyltransferase G9a promotes lung cancer invasion and
metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer
Res. 70:7830–7840. 2010. View Article : Google Scholar : PubMed/NCBI
|
